List of Tables
Table 1. Global Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Acute
Table 3. Key Players of Chronic
Table 4. Global Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Hepatitis B Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hepatitis B Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Hepatitis B Treatment Market Share by Region (2019-2024)
Table 8. Global Hepatitis B Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Hepatitis B Treatment Market Share by Region (2025-2030)
Table 10. Hepatitis B Treatment Market Trends
Table 11. Hepatitis B Treatment Market Drivers
Table 12. Hepatitis B Treatment Market Challenges
Table 13. Hepatitis B Treatment Market Restraints
Table 14. Global Hepatitis B Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Hepatitis B Treatment Market Share by Players (2019-2024)
Table 16. Global Top Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Treatment as of 2023)
Table 17. Ranking of Global Top Hepatitis B Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Hepatitis B Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis B Treatment Product Solution and Service
Table 21. Date of Enter into Hepatitis B Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis B Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Hepatitis B Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Hepatitis B Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Hepatitis B Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Hepatitis B Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Hepatitis B Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Hepatitis B Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Hepatitis B Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Hepatitis B Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Hepatitis B Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Hepatitis B Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Hepatitis B Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Hepatitis B Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Hepatitis B Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Hepatitis B Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Hepatitis B Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Hepatitis B Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Hepatitis B Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Hepatitis B Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Accord Healthcare Inc. Company Detail
Table 47. Accord Healthcare Inc. Business Overview
Table 48. Accord Healthcare Inc. Hepatitis B Treatment Product
Table 49. Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 50. Accord Healthcare Inc. Recent Development
Table 51. Apotex Corp. Company Detail
Table 52. Apotex Corp. Business Overview
Table 53. Apotex Corp. Hepatitis B Treatment Product
Table 54. Apotex Corp. Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 55. Apotex Corp. Recent Development
Table 56. Arbutus Biopharma Company Detail
Table 57. Arbutus Biopharma Business Overview
Table 58. Arbutus Biopharma Hepatitis B Treatment Product
Table 59. Arbutus Biopharma Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 60. Arbutus Biopharma Recent Development
Table 61. Bristol-Myers Squibb Company Company Detail
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Hepatitis B Treatment Product
Table 64. Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Gilead Sciences Company Detail
Table 67. Gilead Sciences Business Overview
Table 68. Gilead Sciences Hepatitis B Treatment Product
Table 69. Gilead Sciences Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 70. Gilead Sciences Recent Development
Table 71. GlaxoSmithKline Company Detail
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Hepatitis B Treatment Product
Table 74. GlaxoSmithKline Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Lupin Pharmaceuticals Company Detail
Table 77. Lupin Pharmaceuticals Business Overview
Table 78. Lupin Pharmaceuticals Hepatitis B Treatment Product
Table 79. Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 80. Lupin Pharmaceuticals Recent Development
Table 81. Merck & Co., Inc. Company Detail
Table 82. Merck & Co., Inc. Business Overview
Table 83. Merck & Co., Inc. Hepatitis B Treatment Product
Table 84. Merck & Co., Inc. Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 85. Merck & Co., Inc. Recent Development
Table 86. Par Pharmaceutical Company Detail
Table 87. Par Pharmaceutical Business Overview
Table 88. Par Pharmaceutical Hepatitis B Treatment Product
Table 89. Par Pharmaceutical Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 90. Par Pharmaceutical Recent Development
Table 91. Teva Pharmaceuticals Company Detail
Table 92. Teva Pharmaceuticals Business Overview
Table 93. Teva Pharmaceuticals Hepatitis B Treatment Product
Table 94. Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 95. Teva Pharmaceuticals Recent Development
Table 96. Zydus Pharmaceuticals Company Detail
Table 97. Zydus Pharmaceuticals Business Overview
Table 98. Zydus Pharmaceuticals Hepatitis B Treatment Product
Table 99. Zydus Pharmaceuticals Revenue in Hepatitis B Treatment Business (2019-2024) & (US$ Million)
Table 100. Zydus Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hepatitis B Treatment Market Share by Type: 2023 VS 2030
Figure 3. Acute Features
Figure 4. Chronic Features
Figure 5. Global Hepatitis B Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Hepatitis B Treatment Market Share by Application: 2023 VS 2030
Figure 7. Immune Modulator Drugs Case Studies
Figure 8. Antiviral Drugs Case Studies
Figure 9. Hepatitis B Treatment Report Years Considered
Figure 10. Global Hepatitis B Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Hepatitis B Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Hepatitis B Treatment Market Share by Region: 2023 VS 2030
Figure 13. Global Hepatitis B Treatment Market Share by Players in 2023
Figure 14. Global Top Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Treatment as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B Treatment Revenue in 2023
Figure 16. North America Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Hepatitis B Treatment Market Share by Country (2019-2030)
Figure 18. United States Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Hepatitis B Treatment Market Share by Country (2019-2030)
Figure 22. Germany Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Hepatitis B Treatment Market Share by Region (2019-2030)
Figure 30. China Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Hepatitis B Treatment Market Share by Country (2019-2030)
Figure 38. Mexico Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Hepatitis B Treatment Market Share by Country (2019-2030)
Figure 42. Turkey Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Hepatitis B Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Accord Healthcare Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 45. Apotex Corp. Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 46. Arbutus Biopharma Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 47. Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 48. Gilead Sciences Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 50. Lupin Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 52. Par Pharmaceutical Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 54. Zydus Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed